Florida Blue prior authorization criteria
Submission criteria, documentation packets, and P2P prep by drug — for prescribers and PA staff. 30-day standard PA decision.
Florida Blue reviews prior-authorization requests against its published medical policies — diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. Standard PA decisions return in 30 days; if denied, prescribers and members have 180 days to appeal. Criteria by drug below.
Prior authorization criteria by drug
Each page covers Florida Blue's submission criteria, the documentation packet, and peer-to-peer prep for that drug.
- Adalimumab at Florida Blue →
- Aflibercept at Florida Blue →
- Apixaban at Florida Blue →
- Atezolizumab at Florida Blue →
- Atogepant at Florida Blue →
- Benralizumab at Florida Blue →
- Bevacizumab at Florida Blue →
- Bictegravir at Florida Blue →
- Buprenorphine at Florida Blue →
- Dapagliflozin at Florida Blue →
- Dulaglutide at Florida Blue →
- Dupilumab at Florida Blue →
- Eculizumab at Florida Blue →
- Elexacaftor Tezacaftor Ivacaftor at Florida Blue →
- Empagliflozin at Florida Blue →
- Erenumab at Florida Blue →
- Evolocumab at Florida Blue →
- Faricimab at Florida Blue →
- Fingolimod at Florida Blue →
- Fremanezumab at Florida Blue →
- Galcanezumab at Florida Blue →
- Glecaprevir Pibrentasvir at Florida Blue →
- Guselkumab at Florida Blue →
- Ibrutinib at Florida Blue →
- Imatinib at Florida Blue →
- Inclisiran at Florida Blue →
- Infliximab at Florida Blue →
- Ixekizumab at Florida Blue →
- Lenalidomide at Florida Blue →
- Liraglutide at Florida Blue →
- Lisdexamfetamine at Florida Blue →
- Mepolizumab at Florida Blue →
- Methylphenidate at Florida Blue →
- Naltrexone at Florida Blue →
- Natalizumab at Florida Blue →
- Nintedanib at Florida Blue →
- Nivolumab at Florida Blue →
- Nusinersen at Florida Blue →
- Ocrelizumab at Florida Blue →
- Ofatumumab at Florida Blue →
- Omalizumab at Florida Blue →
- Ozanimod at Florida Blue →
- Palbociclib at Florida Blue →
- Pembrolizumab at Florida Blue →
- Pirfenidone at Florida Blue →
- Ribociclib at Florida Blue →
- Rimegepant at Florida Blue →
- Risankizumab at Florida Blue →
- Rituximab at Florida Blue →
- Rivaroxaban at Florida Blue →
- Sacubitril Valsartan at Florida Blue →
- Secukinumab at Florida Blue →
- Semaglutide at Florida Blue →
- Sofosbuvir at Florida Blue →
- Tafamidis at Florida Blue →
- Tenofovir Alafenamide at Florida Blue →
- Tezepelumab at Florida Blue →
- Tirzepatide at Florida Blue →
- Tofacitinib at Florida Blue →
- Trastuzumab at Florida Blue →
- Upadacitinib at Florida Blue →
- Ustekinumab at Florida Blue →
Generate a Florida Blue PA packet
Open ApprovalHelp — generate a prior-auth packet tailored to Florida Blue's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com